NDC11 70301200502
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70301-2005-02 | 70301-2005 |
| 70301-2005-2 | 70301-2005 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Temozolomide | TEMOZOLOMIDE | OPKO Pharmaceuticals, LLC | 9dff10ec-6a55-47b6-a458-b7c39e32dc55 | 2026-08-27 | Warnings, Adverse reactions | 70301-2005-2 70301-2005 70301200502 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.